Holen Sie sich die Stockscreener-App
478.32
0.69%
3.29
Überblick
Nachrichten
Preisverlauf
Optionskette
Financials
Warum fällt TMO?
Forum
Prognose
Aktiensplit
Dividendenhistorie
Schlusskurs vom Vortag:
$475.03
Offen:
$479.98
24-Stunden-Volumen:
4.18M
Relative Volume:
1.48
Marktkapitalisierung:
$180.56B
Einnahmen:
$43.21B
Nettoeinkommen (Verlust:
$6.58B
KGV:
27.66
EPS:
17.29
Netto-Cashflow:
$6.17B
1W Leistung:
+15.33%
1M Leistung:
+16.48%
6M Leistung:
-16.79%
1J Leistung:
-19.54%
1-Tages-Spanne:
$474.40
$483.60
1-Wochen-Bereich:
$403.36
$484.60
52-Wochen-Spanne:
$385.46
$627.88
Thermo Fisher Scientific Inc Stock (TMO) Company Profile
Firmenname
Thermo Fisher Scientific Inc
Sektor
Branche
Telefon
(781) 622-1000
Adresse
168 THIRD AVENUE, WALTHAM, MA
Vergleichen Sie TMO mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
TMO
Thermo Fisher Scientific Inc
|
478.32 | 179.32B | 43.21B | 6.58B | 6.17B | 17.29 |
|
DHR
Danaher Corp
|
205.48 | 145.22B | 24.01B | 3.41B | 4.86B | 4.70 |
|
IDXX
Idexx Laboratories Inc
|
565.19 | 44.23B | 3.93B | 894.97M | 837.70M | 10.82 |
|
IQV
Iqvia Holdings Inc
|
199.17 | 34.14B | 15.50B | 1.33B | 2.16B | 7.34 |
|
A
Agilent Technologies Inc
|
120.18 | 34.19B | 6.63B | 1.17B | 1.19B | 4.05 |
Thermo Fisher Scientific Inc Stock (TMO) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-07-11 | Hochstufung | Scotiabank | Sector Perform → Sector Outperform |
| 2025-07-09 | Herabstufung | UBS | Buy → Neutral |
| 2025-01-10 | Hochstufung | Bernstein | Mkt Perform → Outperform |
| 2024-12-23 | Eingeleitet | Scotiabank | Sector Perform |
| 2024-10-14 | Eingeleitet | Redburn Atlantic | Buy |
| 2024-10-01 | Eingeleitet | Stephens | Overweight |
| 2024-08-28 | Eingeleitet | Wells Fargo | Overweight |
| 2024-06-03 | Fortgesetzt | Jefferies | Buy |
| 2024-03-18 | Fortgesetzt | Citigroup | Neutral |
| 2024-01-24 | Herabstufung | Barclays | Overweight → Equal Weight |
| 2024-01-08 | Herabstufung | Bernstein | Outperform → Mkt Perform |
| 2023-12-18 | Eingeleitet | HSBC Securities | Buy |
| 2023-12-13 | Eingeleitet | Wolfe Research | Outperform |
| 2023-10-26 | Herabstufung | KeyBanc Capital Markets | Overweight → Sector Weight |
| 2023-10-25 | Hochstufung | Wells Fargo | Underweight → Equal Weight |
| 2023-09-28 | Eingeleitet | Bernstein | Outperform |
| 2023-09-06 | Fortgesetzt | Citigroup | Buy |
| 2023-07-19 | Eingeleitet | Raymond James | Outperform |
| 2023-07-19 | Bestätigt | Robert W. Baird | Outperform |
| 2023-07-13 | Hochstufung | Credit Suisse | Neutral → Outperform |
| 2023-04-04 | Bestätigt | Barclays | Overweight |
| 2022-12-14 | Eingeleitet | Deutsche Bank | Buy |
| 2022-12-07 | Eingeleitet | RBC Capital Mkts | Outperform |
| 2022-10-27 | Herabstufung | The Benchmark Company | Buy → Hold |
| 2022-08-25 | Eingeleitet | Credit Suisse | Neutral |
| 2022-04-25 | Herabstufung | Wells Fargo | Equal Weight → Underweight |
| 2022-01-26 | Fortgesetzt | Barclays | Overweight |
| 2021-10-20 | Hochstufung | Citigroup | Neutral → Buy |
| 2021-10-15 | Fortgesetzt | Cowen | Outperform |
| 2021-08-05 | Fortgesetzt | Credit Suisse | Outperform |
| 2021-07-16 | Eingeleitet | The Benchmark Company | Buy |
| 2021-03-18 | Hochstufung | KeyBanc Capital Markets | Sector Weight → Overweight |
| 2021-03-03 | Eingeleitet | Barclays | Overweight |
| 2021-01-08 | Hochstufung | Credit Suisse | Neutral → Outperform |
| 2020-12-16 | Herabstufung | Citigroup | Buy → Neutral |
| 2020-12-02 | Eingeleitet | Goldman | Buy |
| 2020-11-10 | Eingeleitet | KeyBanc Capital Markets | Sector Weight |
| 2020-09-30 | Eingeleitet | Atlantic Equities | Overweight |
| 2020-09-14 | Eingeleitet | Morgan Stanley | Overweight |
| 2020-08-20 | Fortgesetzt | JP Morgan | Overweight |
| 2020-07-15 | Hochstufung | Cleveland Research | Neutral → Buy |
| 2020-07-07 | Bestätigt | Needham | Buy |
| 2020-04-23 | Bestätigt | Needham | Buy |
| 2020-01-31 | Bestätigt | Needham | Buy |
| 2020-01-22 | Eingeleitet | Credit Suisse | Neutral |
| 2020-01-08 | Eingeleitet | Wells Fargo | Equal Weight |
| 2020-01-07 | Eingeleitet | Citigroup | Buy |
| 2019-11-15 | Eingeleitet | Stifel | Buy |
| 2019-07-25 | Bestätigt | Needham | Buy |
| 2019-07-16 | Herabstufung | Needham | Strong Buy → Buy |
| 2019-05-30 | Eingeleitet | Wolfe Research | Outperform |
| 2019-05-23 | Bestätigt | Needham | Strong Buy |
| 2019-04-22 | Bestätigt | Needham | Strong Buy |
| 2019-04-16 | Bestätigt | BofA/Merrill | Buy |
Alle ansehen
Thermo Fisher Scientific Inc Aktie (TMO) Neueste Nachrichten
Evercore ISI Raises PT on Thermo Fisher Scientific (TMO) to $525 From $480 - MSN
Is Thermo Fisher Scientific Inc. a good long term investmentFree Stock Index Interpretation - PrintWeekIndia
Trade Deals Fuel Wall Street Gains, Trump Renews Fed Attack: This Week In Markets - Benzinga
Thermo Fisher Scientific (TMO) Unveils New Microscopes At M&M Conference - Yahoo Finance
Fortune 500 Power Moves: Which executives gained and lost power this week, July 19-25, 2025 - Fortune
Thermo Fisher Unit Can’t Undo Executive’s $24 Million Bias Win - Bloomberg Law News
Analyst recommendations: Thermo Fisher Scientific, Intel, Honeywell International, Union Pacific, Gilead Sciences... - MarketScreener
Thermo Fisher Scientific Second Quarter 2025 Earnings: Beats Expectations - simplywall.st
Microplate Readers Market Is Booming So Rapidly 2025-2032 - openPR.com
Thermo Fisher Scientific Increases Accessibility to Research with the Launches of Scios 3 and Talos 12 Electron Microscopes at M&M 2025 Conference - AZoM
ICP-MS System Market Key Players AnalysisPerkinElmer, Inc., - openPR.com
Stifel lowers Thermo Fisher Scientific stock price target to $583 on mixed outlook - Investing.com Canada
What analysts say about Thermo Fisher Scientific Inc. stock outlookMassive portfolio appreciation - jammulinksnews.com
HSBC downgrades Thermo Fisher Scientific stock to Hold on growth concerns - Investing.com
Thermo Fisher Scientific Increases Accessibility to Research With the Launches of Scios 3 and Talos 12 Electron Microscopes at M&M 2025 Conference - StreetInsider
Thermo Fisher Scientific Inc. Ranks 19th in Trading Volume Despite 17.31% Stock Gain in Three Days - AInvest
[Latest] Global CRISPR Gene Editing Market Size/Share Worth USD 12.6 Billion by 2034 at a 13.01% CAGR: Custom Market Insights (Analysis, Outlook, Leaders, Report, Trends, Forecast, Segmentation, Growth Rate, Value, SWOT Analysis) - Yahoo Finance
Thermo Fisher Scientific shares rise 2.73% intraday after announcing new electron microscopes and licensing agreement expansion. - AInvest
Thermo Fisher CFO to retire after decade, internal successor named - The Business Journals
Bernstein raises Thermo Fisher Scientific stock price target on pharma R&D strength - Investing.com
Analyst recommendations: Alphabet, IBM, Thermo Fisher Scientific, Lockheed Martin, ServiceNow... - MarketScreener
Thermo Fisher Scientific Inc. (NYSE:TMO) Q2 2025 Earnings Call Transcript - Insider Monkey
Thermo Fisher Scientific Q2 2025 revenue up 3% to USD 10.85B - Medical Buyer
Company News for Jul 24, 2025 - The Globe and Mail
Thermo Fisher Scientific Inc (TMO) Q2 2025 Earnings Call Highlights: Strong Revenue Growth Amid ... By GuruFocus - Investing.com Canada
Thermo Fisher Scientific’s Chief Financial Officer, Stephen Williamson, to Retire in Early 2026 - BioSpace
Thermo Fisher Scientific Reports Steady Q2 2025 Growth - TipRanks
Thermo Fisher Scientific's Revised Outlook: A Catalyst for Long-Term Growth in Life Sciences and Diagnostics - AInvest
Thermo Fisher Scientific's Q3 2025 Earnings: Assessing Growth Sustainability Amid Life Sciences Surge - AInvest
Thermo Fisher’s Earnings Call Highlights Growth and Challenges - TipRanks
Thermo Fisher Scientific announces CFO retirement and successor appointment - Investing.com
Thermo Fisher Announces CFO Retirement and Successor - TipRanks
Thermo Fisher Scientific Inc. stock rises Wednesday, outperforms market - MarketWatch
TMO announces CFO retirement & internal successor effective 2026 | TMO SEC FilingForm 8-K - Stock Titan
Why Thermo Fischer Stock Is Rising Wednesday - AOL.com
Growth or Bubble? Thermo Fisher’s Market Moves - StocksToTrade
Thermo Fisher's Strong Q2 Performance and Revised Guidance: A Buy Signal Amid a Challenging Sector? - AInvest
Thermo Fisher Scientific (TMO) Reports Earnings Increase and Announces CFO Transition - simplywall.st
Crude Oil Falls; Thermo Fisher Scientific Earnings Top Views - Benzinga
Onshoring trend positions Thermo Fisher for growth - WFMZ.com
Thermo Fisher Scientific's Q2 Outperformance and Strategic Resilience in a Shifting Trade Environment - AInvest
Thermo Fisher (TMO) Shares Skyrocket, What You Need To Know - Yahoo Finance
Thermo Fisher Scientific Stock Jumps on Strong Results, Higher Outlook - MSN
Thermo Fisher flags improving tariff situation, raises annual profit view - Reuters
Thermo Fisher Scientific Appoints Jim Meyer as CFO - citybiz
GE Vernova, Thermo Fisher, Enphase Energy: Trending Tickers - Yahoo Finance
GE Vernova Posts Better-Than-Expected Earnings, Joins Thermo Fisher Scientific, Lennox International, General Dynamics And Other Big Stocks Moving Higher On Wednesday - Benzinga
Market movers: Texas Instruments, Thermo Fisher, GE Vernova... - Proactive financial news
Thermo Fisher Scientific's stock surged during the session, with Q2 revenue exceeding market expectations. - 富途牛牛
Thermo Fisher Q2 Earnings & Revenues Beat, Stock Up in Pre-Market - TradingView
Earnings call transcript: Thermo Fisher beats Q2 2025 forecasts, stock surges - Investing.com
Finanzdaten der Thermo Fisher Scientific Inc-Aktie (TMO)
Umsatz
Nettogewinn
Free Cashflow
ENV
1.32%
0.82%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):